CB
GEHC icon

Chris Bulman’s GE HealthCare GEHC Stock Holding History

Chris Bulman’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-140
Closed -$10.9K – 233
2024
Q2 		$10.9K Buy
+140
New +$11.4K 0.01% 292

Other funds holding GEHC

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
GE
General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Chris Bulman's GEHC Position: Q3 2024 in Review

Chris Bulman sold out of GE HealthCare (GEHC) in Q3 2024, closing a stake of 140 shares — an estimated $10.9K sold.

Chris Bulman first reported a position in GEHC in Q2 2024 and held it in 1 quarter. The position peaked at $10.9K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold GEHC as of Q3 2024.

  • Chris Bulman reported no remaining GE HealthCare position as of Q3 2024 after selling out during the quarter.
  • Chris Bulman sold 140 GE HealthCare shares in Q3 2024, an estimated $10.9K.
  • Chris Bulman first reported a position in GE HealthCare in Q2 2024 and held it in 1 quarter.
  • Chris Bulman's GE HealthCare position peaked at $10.9K in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2024.

Based on Chris Bulman's 13F filing for Q3 2024, filed 22 Oct 2024.